Evidence map›Paper›PMID 41407674›Full record

ArticleNature communications2025

AMP-activated protein kinase-driven lipid droplet dynamics govern melanoma sensitivity to polyunsaturated fatty acid and iron-induced ferroptosis.

Sahar Motamedi, Nina Ravoet, Jonas Dehairs, Frank Vanderhoydonc, Abril Escamilla-Ayala, Malgorzata A Sliwinska, Shuncong Wang, Jakub Idkowiak, Stefaan Soenen, Patrizia Agostinis and 2 more

Abstract read
In one paragraph

Article in Nature communications, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Review
  6. Review
  7. Review
  8. Article
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Sahar MotamediLaboratory of Lipid Metabolism and Cancer, Department of Oncology, LKI - Leuven Cancer Institute, KU Leuven, Leuven, Belgium.ORCID http://orcid.org/0009-0006-6174-1453
Nina RavoetLaboratory of Lipid Metabolism and Cancer, Department of Oncology, LKI - Leuven Cancer Institute, KU Leuven, Leuven, Belgium.ORCID http://orcid.org/0000-0002-9211-7147
Jonas DehairsLaboratory of Lipid Metabolism and Cancer, Department of Oncology, LKI - Leuven Cancer Institute, KU Leuven, Leuven, Belgium.ORCID http://orcid.org/0000-0002-6789-2264
Frank VanderhoydoncLaboratory of Lipid Metabolism and Cancer, Department of Oncology, LKI - Leuven Cancer Institute, KU Leuven, Leuven, Belgium.
Abril Escamilla-AyalaVIB Bio Imaging Core, VIB-KU Leuven Center for Brain & Disease Research, KU Leuven, Leuven, Belgium.ORCID http://orcid.org/0000-0002-5761-0999
Malgorzata A SliwinskaVIB Bio Imaging Core, VIB-KU Leuven Center for Brain & Disease Research, KU Leuven, Leuven, Belgium.ORCID http://orcid.org/0000-0002-5016-4949
Shuncong WangLaboratory of Lipid Metabolism and Cancer, Department of Oncology, LKI - Leuven Cancer Institute, KU Leuven, Leuven, Belgium.
Jakub IdkowiakLaboratory of Lipid Metabolism and Cancer, Department of Oncology, LKI - Leuven Cancer Institute, KU Leuven, Leuven, Belgium.
Stefaan SoenenNanoHealth and Optical Imaging, Department of Imaging & Pathology, KU, Leuven, Leuven, Belgium.ORCID http://orcid.org/0000-0003-2390-3133
Patrizia AgostinisLaboratory of Cell Death Research & Therapy (VIB-KU Leuven), Department of Cellular and Molecular Medicine, KU Leuven, Leuven, Belgium.ORCID http://orcid.org/0000-0003-1314-2115
Jean-Christophe MarineLaboratory for Molecular Cancer Biology, Department of Oncology, KU Leuven, Leuven, Belgium.ORCID http://orcid.org/0000-0003-2433-9837
Johannes V SwinnenLaboratory of Lipid Metabolism and Cancer, Department of Oncology, LKI - Leuven Cancer Institute, KU Leuven, Leuven, Belgium. j.swinnen@kuleuven.be.ORCID http://orcid.org/0000-0002-7720-5077

Funding

Fonds Wetenschappelijk Onderzoek (Research Foundation Flanders) G0C2219N
6 · The paper itself

Abstract

Ferroptosis, a regulated form of cell death driven by lipid peroxidation, holds promise for targeting treatment-resistant cancer cells. Using a panel of melanoma cell lines, we uncover variability in the timing of ferroptosis onset upon exposure to iron and polyunsaturated fatty acids (PUFAs). This heterogeneity is linked to differences in PUFA sequestration into lipid droplets (LDs) and their subcellular distribution, particularly near lipid-metabolizing organelles such as mitochondria. In late-onset models, ferroptosis is delayed by peripheral LD retention and triggered by nutrient deprivation and AMP-activated protein kinase (AMPK) activation, which promotes LD trafficking toward mitochondria. Early responders bypass this mechanism. Our findings identify nutrient status and LD dynamics as key modulators of PUFA- and iron-induced ferroptosis, offering insights for therapeutic exploitation in cancer.

Indexed as

AMP-Activated Protein KinasesFatty Acids, UnsaturatedFerroptosisIronLipid DropletsMelanomaAnimalsCell Line, TumorHumansLipid PeroxidationMitochondriaAMP-Activated Protein KinasesFatty Acids, UnsaturatedIron

Identifiers

PMID41407674
PMCPMC12717062

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.